Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16373 | 592 | 24.5 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1619 | 6500 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PARANEOPLASTIC VASCULITIS | Author keyword | 13 | 80% | 1% | 8 |
2 | PALMAR FASCIITIS | Author keyword | 13 | 69% | 2% | 11 |
3 | LEUKEMIC ARTHRITIS | Author keyword | 9 | 83% | 1% | 5 |
4 | PALMAR FASCIITIS AND POLYARTHRITIS SYNDROME | Author keyword | 6 | 100% | 1% | 4 |
5 | PARANEOPLASTIC POLYARTHRITIS | Author keyword | 3 | 100% | 1% | 3 |
6 | PARANEOPLASTIC RHEUMATIC SYNDROMES | Author keyword | 3 | 100% | 1% | 3 |
7 | CANCER POLYARTHRITIS | Author keyword | 2 | 67% | 0% | 2 |
8 | OCCULT MALIGNOMA | Author keyword | 2 | 67% | 0% | 2 |
9 | PARANEOPLASTIC ARTHRITIS | Author keyword | 1 | 38% | 1% | 3 |
10 | LEUKEMIC SYNOVITIS | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSTCHEMOTHERAPY RHEUMATISM | 9 | 67% | 1% | 8 |
2 | PALMAR FASCIITIS | 9 | 48% | 2% | 13 |
3 | AUTOIMMUNE PHENOMENA | 5 | 29% | 3% | 16 |
4 | CUTANEOUS VASCULITIS | 5 | 13% | 6% | 34 |
5 | SYNOVIAL METASTASIS | 4 | 75% | 1% | 3 |
6 | RHEUMATIC SYNDROMES | 4 | 41% | 1% | 7 |
7 | OCCULT NEOPLASIA | 3 | 60% | 1% | 3 |
8 | LEUCOCYTOCLASTIC VASCULITIS | 2 | 44% | 1% | 4 |
9 | BONE MARROW DYSPLASIA | 2 | 67% | 0% | 2 |
10 | PARANEOPLASTIC SYNDROME | 2 | 19% | 2% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Inflammatory Arthritis in Patients With Myelodysplastic Syndromes A Multicenter Retrospective Study and Literature Review of 68 Cases | 2014 | 5 | 36 | 64% |
Systemic vasculitis in myelodysplastic syndromes | 2012 | 5 | 37 | 70% |
Henoch-Schonlein Purpura Associated With Solid-organ Malignancies: Three Case Reports and a Literature Review | 2012 | 6 | 32 | 59% |
Palmar fasciitis with polyarthritis syndrome in a patient with breast cancer | 2011 | 7 | 8 | 88% |
Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia | 2002 | 61 | 27 | 37% |
Paraneoplastic rheumatic syndromes: report of eight cases and review of literature | 2012 | 2 | 10 | 80% |
Prognosis of vasculitis associated myelodysplasia | 2013 | 3 | 55 | 67% |
Paraneoplastic rheumatologic syndromes | 2013 | 8 | 44 | 32% |
Systemic vasculitis and epithelioma - A report of three cases with a literature review | 1997 | 34 | 29 | 72% |
Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia | 2001 | 36 | 35 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DAVIDOFF COMPREHENS CANC | 1 | 50% | 0.2% | 1 |
2 | HAEMATOL BIOL | 1 | 50% | 0.2% | 1 |
3 | IMMUNOGENET KLIN FARMAKOGENET | 1 | 50% | 0.2% | 1 |
4 | ODDZIAL IMMUNOL KLIN PEDIAT | 1 | 50% | 0.2% | 1 |
5 | OSPED MAGGIORS POLICLIN | 1 | 50% | 0.2% | 1 |
6 | POLICLIN A GEMELLI PATHOL | 1 | 50% | 0.2% | 1 |
7 | RADIAT RADIOTHER Y | 1 | 50% | 0.2% | 1 |
8 | RHEUMATOL MED PATHOL | 1 | 50% | 0.2% | 1 |
9 | ROYAL INFIRM PATHOL | 1 | 50% | 0.2% | 1 |
10 | SERV RHUMATOLLI2PEA4222 | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000167490 | IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//RADIATION THERAPY COMPLICATIONS//STANDARDIZED INCIDENCE RATE |
2 | 0.0000162619 | RS3PE//REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA//RS3PE SYNDROME |
3 | 0.0000145056 | AUTOIMMUNE MYELOFIBROSIS//DACRYOCYTES//ABNORMAL LOCALIZATION OF IMMATURE PRECURSORS ALIP |
4 | 0.0000132368 | CHROMOSOME 5 ABNORMALITY//PHARM NTHC NARILIS//UNIDAD HEMATOL CLIN |
5 | 0.0000109696 | HENOCH SCHONLEIN PURPURA//LEUKOCYTOCLASTIC VASCULITIS//HENOCH SCHONLEIN PURPURA NEPHRITIS |
6 | 0.0000096248 | SYMPTOM INTERVAL//GROWING PAINS//GROWING PAIN |
7 | 0.0000093274 | ACANTHOSIS NIGRICANS//BAZEX SYNDROME//ERYTHEMA GYRATUM REPENS |
8 | 0.0000091171 | HYPERTROPHIC OSTEOARTHROPATHY//PACHYDERMOPERIOSTOSIS//HYPERTROPHIC OSTEOPATHY |
9 | 0.0000082880 | RELAPSING POLYCHONDRITIS//POLYCHONDRITIS RELAPSING//AURICULAR CHONDRITIS |
10 | 0.0000077091 | RENAL LYMPHOMA//PRIMARY RENAL LYMPHOMA//PARANEOPLASTIC NEPHROTIC SYNDROME |